A Study of PHN-012 in Patients With Advanced Solid Tumors
NCT07127874
·
clinicaltrials.gov ↗
PHASE1
Phase
RECRUITING
Status
165
Enrollment
INDUSTRY
Sponsor class
Conditions
Colon Cancer
Pancreatic Cancer
Lung Cancer (NSCLC)
Advanced Cancer
Advanced Solid Tumors
Interventions
DRUG:
PHN-012
Sponsor
Pheon Therapeutics